Transaction · 0001562180-25-001684

McAnaney Adam

McAnaney Adam, CLO, reported a transaction classified as grant at Oscar Health, Inc. involving 185004.000000 shares for an estimated $0.00. Reported holdings after the transaction were 185004.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACLO
OSCROscar Health, Inc.
Filing timeFeb 26
Trade dateFeb 24, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
Pre-filing
Returns since

OSCR price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
OSCR since 2025-02-26Filed 560 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001562180-25-001684
Stock Options (Right to buy)
Transaction date
Feb 24, 2025
Filed Feb 26, 2025, 09:21 PM · 2d delay
Shares
185k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
185k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Legal Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The shares represent restricted stock units, which will vest over four years with 25% vesting on March 1, 2026 and the remaining 75% vesting thereafter in 12 equal quarterly installments, subject to t…

  2. F2

    Includes shares to be issued in connection with the vesting of one or more restricted stock units

  3. F3

    The options will vest over four years with 25% vesting on March 1, 2026 and the remaining 75% vesting thereafter in 12 equal quarterly installments, subject to the reporting person's continuous servic…

Original filing · 0001562180-25-001684
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

OSCR